 |
 |
Articles about the legal decision in the GDNF case are available at http://grassrootsconnection.com/grcissue_GDNF_research.htm and http://pdpipeline.org/focus_updates.htm Basically the judge ruled against the trial participants on the basis of contractual issues -- that the informed consent form they signed at the beginning of the trial did not require Amgen to continue their treatments after halting the trial. None of the other issues - the contested trial results, the questions about the safety issues being overstated, nor the morality of denying treatments that worked for many of trial participants were considered in the judge's decision. This case should teach all of us that before enrolling in future clinical trials we should very carefully consider what's included or not included in the informed consent forms .This is an issue the Parkinson Pipeline Project is working on, along with a "Research Participants' Bill of Rights" For more info see http://pdpipeline.org/rights.htm Linda ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn